203 related articles for article (PubMed ID: 12965902)
41. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice.
Noel N; André C; Bengoufa D; Dehoulle C; Mahler M; Limal N; Godeau B; Hüe S
Autoimmun Rev; 2013 Oct; 12(12):1118-22. PubMed ID: 23800447
[TBL] [Abstract][Full Text] [Related]
42. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
Specks U; Wiegert EM; Homburger HA
Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
[TBL] [Abstract][Full Text] [Related]
43. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
[TBL] [Abstract][Full Text] [Related]
44. Borderline positive antineutrophil cytoplasmic antibodies (ANCA)-PR3/MPO detection in a large cohort tertiary center: lessons learnt from a real-life experience.
Watad A; Bragazzi NL; Sharif K; Gilburd B; Yavne Y; McGonagle D; Amital H; Shoenfeld Y
Clin Chem Lab Med; 2018 May; 56(6):947-953. PubMed ID: 29374761
[TBL] [Abstract][Full Text] [Related]
45. A novel strategy with combined assays for detection of anti-neutrophil cytoplasmic antibody (ANCA) in clinically ANCA-negative granulomatosis with polyangiitis patients.
Tateyama K; Kodama S; Kishibe K; Harabuchi Y; Suzuki M
Auris Nasus Larynx; 2017 Dec; 44(6):735-741. PubMed ID: 28666565
[TBL] [Abstract][Full Text] [Related]
46. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
[TBL] [Abstract][Full Text] [Related]
47. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
Han WK; Choi HK; Roth RM; McCluskey RT; Niles JL
Kidney Int; 2003 Mar; 63(3):1079-85. PubMed ID: 12631091
[TBL] [Abstract][Full Text] [Related]
48. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
Savige J; Trevisin M; Pollock W
J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
[TBL] [Abstract][Full Text] [Related]
49. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
[TBL] [Abstract][Full Text] [Related]
50. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes.
Westman KW; Bygren PG; Eilert I; Wiik A; Wieslander J
Nephrol Dial Transplant; 1997 Sep; 12(9):1863-8. PubMed ID: 9306336
[TBL] [Abstract][Full Text] [Related]
51. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
52. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.
Flores-Suárez LF; Cabiedes J; Villa AR; van der Woude FJ; Alcocer-Varela J
Rheumatology (Oxford); 2003 Feb; 42(2):223-9. PubMed ID: 12595614
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
Sowa M; Grossmann K; Knütter I; Hiemann R; Röber N; Anderer U; Csernok E; Bogdanos DP; Borghi MO; Meroni PL; Schierack P; Reinhold D; Conrad K; Roggenbuck D
PLoS One; 2014; 9(9):e107743. PubMed ID: 25225805
[TBL] [Abstract][Full Text] [Related]
55. Interference of anti-nuclear antibodies on determination of anti-neutrophil cytoplasmic antibodies in patients suspected of vasculitis: a case series.
Mahto M; Rai N; Das PR; Karmakar S; Bhushan D
Biochem Med (Zagreb); 2023 Oct; 33(3):031001. PubMed ID: 37545697
[TBL] [Abstract][Full Text] [Related]
56. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
[TBL] [Abstract][Full Text] [Related]
57. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.
Choi HK; Lamprecht P; Niles JL; Gross WL; Merkel PA
Arthritis Rheum; 2000 Jan; 43(1):226-31. PubMed ID: 10643719
[TBL] [Abstract][Full Text] [Related]
58. PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.
van Dam LS; Dirikgil E; Bredewold EW; Ray A; Bakker JA; van Kooten C; Rabelink TJ; Teng YKO
Nephrol Dial Transplant; 2021 Jul; 36(8):1408-1417. PubMed ID: 32601673
[TBL] [Abstract][Full Text] [Related]
59. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
60. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
